NUVAXOVID was authorized by Health Canada on February 17, 2022. In order to provide earlier access to NUVAXOVID in the context of the global pandemic, Novavax, Inc. will distribute product vials, cartons and package inserts that are in English only for a period of time. The English-only vial and carton labels are missing some important Canadian-specific information normally found on Health Canada approved labels (see the Information for healthcare professionals section).
RecallTracker